Skip to main content
. 2024 Jun 30;65(2):225–241. doi: 10.47162/RJME.65.2.09

Table 3.

The peculiarities observed in the different benign tumor types found in our study population, using percentages [n, (%)]

Peculiarities of benign tumors

Total

SCA

MCA

BCA

AF

Fibroma

MT

Gonadoblastoma

SST

Cysts

Age [years]

 Prepuberty (0–9)

15

2 (13%)

1 (7%)

0 (0%)

0 (0%)

0 (0%)

6 (40%)

0 (0%)

0 (1%)

6 (40%)

 Puberty (10–17)

97

15 (15%)

9 (9%)

3 (3%)

1 (1%)

2 (2%)

18 (19%)

1 (1%)

1 (1%)

47 (49%)

Sex

 Male

7

2 (29%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

2 (29%)

0 (0%)

0 (0%)

3 (43%)

 Female

105

15 (14%)

10 (10%)

3 (3%)

1 (1%)

2 (2%)

22 (21%)

1 (1%)

1 (1%)

50 (48%)

Size [cm]

 <5

27

8 (30%)

3 (11%)

1 (4%)

0 (0%)

0 (0%)

3 (11%)

0 (0%)

0 (0%)

12 (44%)

 5–10

63

6 (10%)

5 (8%)

1 (2%)

1 (2%)

0 (0%)

19 (30%)

0 (0%)

0 (0%)

31 (49%)

 >10

22

3 (14%)

2 (9%)

1 (5%)

0 (0%)

2 (9%)

2 (9%)

1 (5%)

1 (5%)

10 (45%)

Tumor location

 Right

47

10 (21%)

4 (9%)

2 (4%)

0 (0%)

2 (4%)

7 (15%)

0 (0%)

0 (0%)

22 (47%)

 Left

55

6 (11%)

5 (9%)

1 (2%)

1 (2%)

0 (0%)

16 (29%)

0 (0%)

1 (2%)

25 (45%)

 Both sides

10

1 (10%)

1 (10%)

0 (0%)

0 (0%)

0 (0%)

1 (10%)

1 (10%)

0 (0%)

6 (60%)

Pain location

 Right

31

7 (22.6%)

3 (9.7%)

0 (0%)

0 (0%)

1 (3.2%)

6 (19.4%)

0 (0%)

0 (0%)

12 (38.7%)

 Left

56

7 (12.5%)

7 (12.5%)

1 (1.8%)

0 (0%)

0 (0%)

15 (26.8%)

0 (0%)

1 (1.8%)

28 (50%)

 Both sides

20

2 (10%)

0 (0%)

2 (10%)

1 (5%)

1 (5%)

2 (10%)

0 (0%)

0 (0%)

11 (55%)

Pain radiates to leg

27

6 (22%)

4 (15%)

1 (4%)

1 (4%)

0 (0%)

10 (37%)

1 (4%)

0 (0%)

4 (15%)

Repetition

7

1 (14%)

0 (0%)

2 (29%)

0 (0%)

1 (14%)

1 (14%)

0 (0%)

0 (0%)

2 (29%)

Prenatal diagnosis

6

1 (17%)

1 (17%)

1 (17%)

0 (0%)

0 (0%)

1 (17%)

0 (0%)

0 (0%)

2 (33%)

Gonadectomy

27

5 (19%)

2 (7%)

2 (7%)

1 (4%)

0 (0%)

9 (33%)

0 (0%)

0 (0%)

8 (30%)

Asymptomatic

5

1 (20%)

1 (20%)

0 (0%)

0 (0%)

0 (0%)

1 (20%)

0 (0%)

0 (0%)

2 (40%)

Appendicitis

19

2 (11%)

4 (21%)

1 (5%)

0 (0%)

1 (5%)

2 (11%)

0 (0%)

0 (0%)

9 (47%)

Loss of appetite

19

9 (47%)

5 (26%)

2 (11%)

1 (5%)

0 (0%)

1 (5%)

0 (0%)

0 (0%)

1 (5%)

Loss of weight

5

2 (40%)

1 (20%)

2 (40%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Leukocytosis

35

9 (26%)

3 (9%)

1 (3%)

1 (3%)

1 (3%)

5 (14%)

0 (0%)

0 (0%)

15 (43%)

Fever

11

1 (9%)

2 (18%)

0 (0%)

0 (0%)

1 (9%)

2 (18%)

0 (0%)

0 (0%)

5 (45%)

Constipation

8

2 (25%)

1 (13%)

0 (0%)

0 (0%)

0 (0%)

2 (25%)

0 (0%)

0 (0%)

3 (38%)

Vomit

7

0 (0%)

2 (29%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

5 (71%)

Bleeding

7

0 (0%)

2 (29%)

0 (0%)

1 (14%)

1 (14%)

1 (14%)

0 (0%)

0 (0%)

2 (29%)

Abdominal distention

24

2 (8%)

1 (4%)

1 (4%)

0 (0%)

2 (8%)

9 (38%)

1 (4%)

1 (4%)

7 (29%)

Ascites

4

1 (25%)

1 (25%)

0 (0%)

0 (0%)

0 (0%)

1 (25%)

0 (0%)

0 (0%)

1 (25%)

GCT

25

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

24 (96%)

1 (4%)

0 (0%)

0 (0%)

Not GCT

87

17 (20%)

10 (11%)

3 (3%)

1 (1%)

2 (2%)

0 (0%)

0 (0%)

1 (1%)

53 (61%)

Loculation

 Unilocular cyst

39

5 (13%)

1 (3%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

33 (85%)

 Unilocular cyst + solid

20

7 (35%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

4 (20%)

1 (5%)

0 (0%)

8 (40%)

 Multilocular cyst

28

2 (7%)

9 (32%)

0 (0%)

1 (4%)

1 (4%)

5 (18%)

0 (0%)

0 (0%)

10 (36%)

 Multilocular cyst + solid

21

3 (14%)

0 (0%)

1 (5%)

0 (0%)

1 (5%)

13 (62%)

0 (0%)

1 (5%)

2 (10%)

 Multilocular solid

4

0 (0%)

0 (0%)

2 (50%)

0 (0%)

0 (0%)

2 (50%)

0 (0%)

0 (0%)

0 (0%)

 Solid

0

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Compressed organs

16

6 (38%)

2 (13%)

1 (6%)

0 (0%)

0 (0%)

1 (6%)

0 (0%)

0 (0%)

6 (38%)

Viruses

6

2 (33%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

2 (33%)

0 (0%)

1 (17%)

1 (17%)

Elevated tumor markers

8

1 (13%)

1 (13%)

2 (25%)

0 (0%)

0 (0%)

3 (38%)

0 (0%)

0 (0%)

1 (13%)

AF: Adenofibroma; BCA: Borderline cystadenoma; GCT: Germ cell tumor; MCA: Mucinous cystadenoma; MT: Mature teratoma; n: No. of cases; SCA: Serous cystadenoma; SST: Sclerosing stromal tumor.